Volume 20 No 12 (2022)
 Download PDF
Role of Fluorine-18 Labelled PSMA PET/CT Imaging in Prostatic Cancer Patients with Biochemical Recurrence
Amr A. Elfattah Hassan Gadalla , Mohamed A. Moneim Salim Mostafa , Tamer Wahid Mahmoud Kassem , Nahla Dessoki Elsayed and Mohamed Fouad Osman
Abstract
The second most common type of cancer in men is prostate cancer and the sixth most frequent cancer-related mortality cause in the world. The goal of curative treatment for patients with localized advanced prostate cancer is to completely eradicate the condition, although within ten years, up to 32% of individuals would get a biochemical recurrence. It has been demonstrated that the PSMA ligand is more sensitive and focused. The ability to detect cancers, including minute visceral, osseous, and lymph node metastases, even at low PSA levels is the major advantage
Keywords
prostate cancer- PET/CT- PSMA- SUVmax- PSA
Copyright
Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.